APS 2011 Chronic Non-Cancer Pain

APS 2011 Chronic Non-Cancer Pain

Brain, Behavioral Effects of Duloxetine Observed in Patients with Chronic Low Back Pain

Initial analysis of the effects of duloxetine vs. placebo in patients with chronic low back pain indicates duloxetine has both brain and behavioral effects in this population, Kevin A. Johnson, of Stanford University School of Medicine, Palo Alto, CA, and colleagues reported during the American Pain Society’s 30th Annual Scientific Meeting.

Sublingual Dexmedetomidine Shows Analgesic Efficacy in Patients with Chronic Low Back Pain

Patients with chronic low back pain treated with REC1100, a sublingual formulation of dexmedetomidine, showed a significant decrease in mean Visual Analog Scale of Pain (VASPain) scores two hours after dosing compared with those receiving placebo, investigators reported during the American Pain Society’s 30th Annual Scientific Meeting.